September 3, 2020
UK-based data capture software company, uMotif, has raised £5 million in a Series A investment round led by existing investor AlbionVC.
The funding will accelerate uMotif’s growth and enable further development of its patient-centric and decentralised approach to clinical studies and enable expansion into new study types and more high-demand territories.
WHY IT MATTERS
Life sciences companies...
June 25, 2020
Historically, women have been underrepresented in clinical trials, however, that paradigm is changing. This shift is mainly due to policy changes in the last three decades, but today many innovators are also seeing a role for tech to play in closing this gap.
This morning MobiHealthNews sat down with a panel at Women of Wearables’ FemTech Forum to moderate a discussion about the gender gap in...
December 5, 2019
The FDA and National Institutes of Health are tapping the clinical community and a newly launched mobile platform in its search for novel infectious disease interventions.
Called CURE ID, the online data repository will allow clinicians to report instances in which existing FDA-approved drugs are used to successfully treat infections.
In particular, the tool captures clinical outcomes in cases...
October 14, 2019
Atlanta-based Florence Healthcare, a maker of software for clinical trials, has raised $7.1 million in a Series B funding round led by Fulcrum Equity Partners, with additional participation from Atrium Health and Bee Partners.
The round brings the company's total funding to at least $8.8 million, with a $1.7 million seed round from 2016.
WHAT THEY DO
Not to be confused with the UK social care...
October 1, 2019
Novartis is teaming up with Microsoft on a new artificial intelligence initiative focused on drug discovery and development. The new efforts will primarily be focused in Novartis’ newly announced AI innovation lab.
As part of the deal Novartis will be employing Microsoft’s AI tools to help its scientist with computational hurdles in life sciences including generative chemistry, image...
July 29, 2019
Last week, Eko Devices announced a new service that matches ECG and heart sound recordings with clinical data to help pinpoint novel drug-data combinations. The Silicon Valley startup is pitching the platform, called Eko Home, as a resource for clinical trials targeting new therapies.
The new platform is already seeing some action. According to the company, an ongoing Mayo Clinic study exploring...
July 3, 2019
Cloud technology opens up the potential for exciting innovations when it comes to the design and execution of clinical trials, but data security and privacy concerns are holding innovation at a snail’s pace.
Despite these misgivings, cloud-based solutions could in fact offer greater security, as well as the ability to access large pools of data that would improve an organization’s ability to...
March 29, 2019
At MEDinIsrael 2019 this week, a conference in Tel Aviv sponsored by the Israeli Export Institute, Dr. Lena Granovsky, director of analytics and big data at Teva Pharmaceuticals, spoke on and off stage about the work the top Israeli pharma company has been doing in digital health. These topics included the company's recently FDA-cleared smart inhaler ProAir Digihaler, as well as more broad...
February 27, 2019
Researchers who use Fitabase to capture data from Fitbit and Garmin devices will soon be able to capture a new kind of data: continuous glucose monitoring data from Dexcom products.
The ability to capture glucose values, as well as calibrations, syncs, and alerts, from Dexcom CGMs will allow researchers to study the interplay between blood glucose and the activity, heart rate, and sleep — the...
February 20, 2019
Looking to innovate in the research space, pharma giant Pfizer inked a deal with Ochsner Health System, a Louisiana academic healthcare system, to develop digital tools for clinical trials. The partners will be using Ochsner’s innovation lab, innovationOchsner, and Ochsner Research.
The multi-year strategic alliance revolves around a goal of improving “access and connectivity to clinical trials...